Add
ELTP.OB to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| ELTP.OB > SEC Filings for ELTP.OB > Form 8-K on 27-Jan-2012 | All Recent SEC Filings |
27-Jan-2012
Other Events, Financial Statements and Exhibits
On January 23, 2012, the Company received a letter from the US Food and Drug Administration approving the supplement filed by the Company with the agency to change the manufacturing and packaging location of the Hydromorphone Hydrochloride Tablets USP, 8 mg ANDA purchased from Mikah Pharma.
A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
a) Not applicable.
b) Not applicable.
c) Not applicable.
d) Exhibits
Exhibit No. Exhibit
99.1 Press Release dated January 26, 2012
|
|